Zobrazeno 1 - 10
of 175
pro vyhledávání: '"Cheadle, E J"'
Autor:
Cheadle, E. J., Lipowska-Bhalla, G., Dovedi, S. J., Fagnano, E., Klein, C., Honeychurch, J., Illidge, T. M.
Publikováno v:
Cheadle, E J, Lipowska-Bhalla, G, Dovedi, S J, Fagnano, E, Klein, C, Honeychurch, J & Illidge, T M 2017, ' A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells (vol 31, pg 1611, 2017) ' Leukemia, vol 31, no. 10, pp. 2278-2278 . DOI: 10.1038/leu.2016.352
Cheadle, E J, Lipowska-Bhalla, G, Dovedi, S J, Fagnano, E, Klein, C, Honeychurch, J & Illidge, T M 2017, ' A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells (vol 31, pg 1611, 2017) ', Leukemia, vol. 31, no. 10, pp. 2278-2278 . https://doi.org/10.1038/leu.2016.352
Cheadle, E J, Lipowska-Bhalla, G, Dovedi, S J, Fagnano, E, Klein, C, Honeychurch, J & Illidge, T M 2017, ' A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells (vol 31, pg 1611, 2017) ', Leukemia, vol. 31, no. 10, pp. 2278-2278 . https://doi.org/10.1038/leu.2016.352
Anti-CD20 monoclonal antibodies (mAb) such as rituximab have been proven to be highly effective at improving outcome in B-cell malignancies. However, many patients ultimately relapse and become refractory to treatment. The glycoengineered anti-CD20 m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c1346ea34ddd57b017f69a04f796678f
https://doi.org/10.1038/leu.2016.352
https://doi.org/10.1038/leu.2016.352
Publikováno v:
Gene Therapy. Nov2012, Vol. 19 Issue 11, p1114-1120. 7p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Radford, K J, Higgins, D E, Pasquini, S, Cheadle, E J, Carta, L, Jackson, A M, Lemoine, N R, Vassaux, G
Publikováno v:
Gene Therapy; 11/1/2002, Vol. 9 Issue 21, p1455, 9p
Autor:
Tong, Mingfu, Liu, Huimin, Xu, Huan, Liu, Shenying, Hu, Yangyang, Wang, Zhizhi, Chen, Youxiang, Wang, Jian
Publikováno v:
Biotechnology & Genetic Engineering Reviews; Nov2024, Vol. 40 Issue 3, p1774-1790, 17p
Publikováno v:
Biomedicines; Aug2024, Vol. 12 Issue 8, p1721, 16p
Autor:
Dagar, Gunjan, Gupta, Ashna, Shankar, Abhishek, Chauhan, Ravi, Macha, Muzafar A., Bhat, Ajaz A., Das, Dayasagar, Goyal, Rajeev, Bhoriwal, Sandeep, Pandita, Raj K., Prasad, Chandra Prakash, Sarkar, Partha S., Pandita, Tej K., Singh, Mayank
Publikováno v:
Frontiers in Molecular Biosciences; 2024, p01-17, 17p
Autor:
Capaccione, Kathleen M.1 (AUTHOR), Doubrovin, Mikhail1 (AUTHOR) md2367@cumc.columbia.edu, Braumuller, Brian1 (AUTHOR), Leibowitz, Dev1 (AUTHOR), Bhatt, Nikunj1 (AUTHOR), Momen-Heravi, Fatemeh2 (AUTHOR), Molotkov, Andrei1 (AUTHOR), Kissner, Michael3 (AUTHOR), Goldner, Kimberly1 (AUTHOR), Soffing, Mark1 (AUTHOR), Ali, Alessandra1 (AUTHOR), Mintz, Akiva1 (AUTHOR) md2367@cumc.columbia.edu
Publikováno v:
Cancers. Oct2022, Vol. 14 Issue 19, p4575. 14p.
Autor:
Fangyuan Li
Publikováno v:
Journal of Humanities & Social Sciences Studies (JHSSS); May2024, Vol. 6 Issue 5, p7-12, 6p
Autor:
Hirobe, Sachiko1,2,3 (AUTHOR) hirobe-s@phs.osaka-u.ac.jp, Imaeda, Keisuke4 (AUTHOR) imakei0716@gmail.com, Tachibana, Masashi4,5 (AUTHOR) tacci@phs.osaka-u.ac.jp, Okada, Naoki4,5 (AUTHOR) okada@phs.osaka-u.ac.jp
Publikováno v:
International Journal of Molecular Sciences. Apr2022, Vol. 23 Issue 7, p4056-N.PAG. 15p.